Lung Deposition of Beclometasone Dipropionate/Formoterol Fumarate/Glycopyrronium Bromide Administered Via pMDI in Healthy, Asthmatic and COPD Patients
Clinical trial NCT02975843 · COMPLETED
Trial details
- NCT number
- NCT02975843
- Sponsor
- Chiesi Farmaceutici S.p.A.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-21
- Primary completion
- 2017-03-21
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.